Patents by Inventor Fauad Hasan

Fauad Hasan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INITIATING NEUROTOXIN TREATMENTS
    Publication number: 20230058666
    Abstract: Disclosed herein are compositions and methods for use in initiating neurotoxin treatments.
    Type: Application
    Filed: April 20, 2022
    Publication date: February 23, 2023
    Inventors: Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR USE IN THERAPY
    Publication number: 20230027850
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures.
    Type: Application
    Filed: February 28, 2022
    Publication date: January 26, 2023
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN MINIMIZING SCARRING
    Publication number: 20220395561
    Abstract: Methods to minimize scarring during the wound healing process are described. Methods to improve appearance of a scar that forms over a wound are also described. The methods comprise administering a therapeutically effective amount of botulinum toxin subtype E (BoNT/E) in the proximity of a wound.
    Type: Application
    Filed: March 30, 2022
    Publication date: December 15, 2022
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
    Publication number: 20220370574
    Abstract: Disclosed herein are compositions and methods for use in treating hyperhidrosis.
    Type: Application
    Filed: March 23, 2022
    Publication date: November 24, 2022
    Inventors: Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN INHIBITING CGRP
    Publication number: 20220306704
    Abstract: Disclosed herein are compositions and methods for use in inhibiting CGRP production and release.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 29, 2022
    Inventors: Michael Jarpe, Fauad Hasan
  • NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION
    Publication number: 20220226446
    Abstract: Disclosed herein are compositions and methods for use in reducing lung function inhibition.
    Type: Application
    Filed: December 2, 2021
    Publication date: July 21, 2022
    Inventors: Fauad Hasan, Wajdie Ahmad, Sawsan Abushakra
  • Botulinum neurotoxins for use in therapy
    Patent number: 11260114
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: March 1, 2022
    Assignee: Bonti, Inc.
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE
    Publication number: 20210145955
    Abstract: Disclosed herein are compositions and methods for use in neurotoxin treatments.
    Type: Application
    Filed: June 26, 2018
    Publication date: May 20, 2021
    Inventors: Kenton Abel, Michael Jarpe, Fauad Hasan
  • BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
    Publication number: 20210106660
    Abstract: Disclosed herein are compositions and methods for use in treating hyperhidrosis.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 15, 2021
    Inventors: Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR USE IN THERAPY
    Publication number: 20200046814
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
    Type: Application
    Filed: March 22, 2018
    Publication date: February 13, 2020
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • INITIATING NEUROTOXIN TREATMENTS
    Publication number: 20200038492
    Abstract: Disclosed herein are compositions and methods for use in initiating neurotoxin treatments.
    Type: Application
    Filed: April 20, 2018
    Publication date: February 6, 2020
    Inventors: Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR TREATING TRAUMATIC INJURIES
    Publication number: 20200023044
    Abstract: Disclosed herein are compositions and methods for use in treating injuries.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 23, 2020
    Applicant: Bonti, Inc.
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN INHIBITING CGRP
    Publication number: 20190300583
    Abstract: Disclosed herein are compositions and methods for use in inhibiting CGRP production and release.
    Type: Application
    Filed: April 3, 2019
    Publication date: October 3, 2019
    Inventors: Michael Jarpe, Fauad Hasan
  • NEUROTOXINS FOR USE IN MINIMIZING SCARRING
    Publication number: 20190183987
    Abstract: Methods to minimize scarring during the wound healing process are described. Methods to improve appearance of a scar that forms over a wound are also described. The methods comprise administering a therapeutically effective amount of botulinum toxin subtype E (BoNT/E) in the proximity of a wound.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION
    Publication number: 20190125844
    Abstract: Disclosed herein are compositions and methods for use in reducing lung function inhibition.
    Type: Application
    Filed: November 1, 2018
    Publication date: May 2, 2019
    Inventors: Fauad Hasan, Wajdie Ahmad, Sawsan Abushakra
  • Mixing Systems and Related Mixers
    Publication number: 20060280028
    Abstract: A mixing system includes a housing and a motor mount disposed on the housing and having a passage extending therethrough. A dive motor is coupled with the motor mount for selectively rotating the motor mount relative to the housing. A rotational assembly includes a hub having a passageway extending therethrough and a casing at least partially encircling the hub, the hub being rotatable to the casing. The rotational assembly is removably coupled to the housing so that the passageway of the hub aligns with the passage of the motor mount.
    Type: Application
    Filed: April 20, 2006
    Publication date: December 14, 2006
    Applicants: Hyclone Laboratories, Inc., Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Derik West, Whitt Woods, Jeremy Larsen, Nephi Jones, Robert Oakley, Kurt Kunas, Fauad Hasan
  • Stirred-tank reactor system
    Publication number: 20050239199
    Abstract: The present invention relates to a stirred-tank reactor system and methods of preparing such systems. The present invention further encompasses the use of the stirred-tank reactor system as a disposable bioreactor and in kits with disposable elements.
    Type: Application
    Filed: April 22, 2005
    Publication date: October 27, 2005
    Applicants: Baxter International Inc., Baxter Healthcare S.A., HyClone Laboratories, Inc.
    Inventors: Kurt Kunas, Robert Oakley, Fauad Hasan, Michael Goodwin, Jeremy Larsen, Nephi Jones